People: Transition Therapeutics Inc (TTH.TO)
30 Jun 2016
Dr. Tony Cruz is Chairman of the Board, Chief Executive Officer of Transition Therapeutics Inc. Dr. Cruz is one of the founders of Transition Therapeutics and has held the position of Chief Executive Officer of Transition Therapeutics since its inception in July 1998. Dr. Cruz was a Co-Founder, Vice-President and Director at Angiotech Pharmaceuticals Inc. Dr. Cruz has been a Senior Scientist at Mount Sinai Hospital since 1995 and was the CEO and President of the Canadian Arthritis Network until 2001. He has also served as a consultant for biotechnology companies and investment firms.
|Total Annual Compensation, CAD||423,300|
|Restricted Stock Awards, CAD||--|
|Long-Term Incentive Plans, CAD||--|
|All Other, CAD||1,576|
|Fiscal Year Total, CAD||424,876|